Anti-tetanus immunoglobulin
GlaxoSmithKline) | |
Clinical data | |
---|---|
Trade names | HyperTET S/D, others |
Other names | tetanus immune globulin, tetanus antitoxin |
AHFS/Drugs.com | Monograph |
Routes of administration | IM |
Identifiers | |
CAS Number | |
ChemSpider |
|
Anti-tetanus immunoglobulin, also known as tetanus immune globulin (TIG) and tetanus antitoxin, is a medication made up of
Common side effects include pain at the site of injection and fever.
The immunoglobulin is categorized as immunoglobulin G (IgG).[4] Since the tetanus toxin permanently binds to human tissues, only unbounded molecules can be neutralized by the immunoglobulin.[2]
Use of the horse version became common in the 1910s, while the human version came into frequent use in the 1960s.
References
- ^ a b c d e f g h "Tetanus Immune Globulin". The American Society of Health-System Pharmacists. Archived from the original on 9 January 2017. Retrieved 8 January 2017.
- ^ PMID 32644434, retrieved 2022-08-08
- ^ "Tetanus immune globulin Use During Pregnancy | Drugs.com". www.drugs.com. Archived from the original on 9 January 2017. Retrieved 8 January 2017.
- ^ PMID 30000001, retrieved 2022-08-08
- ^ ISBN 9780128037089. Archivedfrom the original on 2017-01-09.
- ISBN 978-1455700905. Archivedfrom the original on 2017-01-09.
- hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
- ISBN 9780071641142. Archivedfrom the original on 2017-01-09.